The APAC animal health Market is projected to reach a value of USD 22.1 billion by 2025 from USD 15.6 billion in 2020,at a CAGR of 7.2% during the forecast period. Factors such as the rapid rise in livestock population, increasing awareness about animal health, and rising frequency of animal disease outbreaks are expected to drive the growth of the APAC animal health market. However, restrictions on the use of parasiticides in food-producing animals, shift toward vegetarian diets, and the rising cost of storage of animal vaccines are expected to restrain the growth of this market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=106215485

Browse in-depth TOC on "APAC animal health Market”

142 – Tables

59 – Figures

253 – Pages

Key Market Players:

The prominent players operating in this market include Boehringer Ingelheim (Germany), Zoetis Inc. (US), Elanco Animal Health (US), Merck & Co. Inc (US), Phibro Animal Health (US), Virbac (France), Vetoquinol S.A (France), Ceva Sante Animale (France), Dechra Pharmaceuticals Plc. (UK), Kyoritsu Seiyako (Japan), Tianjin Ringpu (China), China Animal Husbandry (China), and Jinyu Bio-Technology (China). These players adopted partnerships, agreements, and acquisitions to expand their presence in APAC animal health market.

Request Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=106215485

Zoetis

Zoetis provides highly diversified products for a wide range of animal species. The company’s broad geographic diversity has enabled it to deliver its animal healthcare products to more than 110 countries across the globe. To maintain its position in the animal parasiticides market, the company focuses on providing innovative products, building a strong geographical network, and enhancing its R&D to deliver measurable and beneficial results for animals. In February 2020, Zoetis launched Simparica Trio, a parasiticide for dogs with, or at risk from mixed external and internal parasitic infestations.

Boehringer Ingelheim

Boehringer Ingelheim’s strong focus on R&D and investments in collaborations, partnerships, and acquisitions have ensured its position in the market. It focuses on expansions to strengthen its geographic footprint, presence, and growth. For instance, in August 2019, Boehringer opened a Health Management Center in China. The center integrates animal disease and health diagnostics as well as monitoring tools to maintain and enhance animal health.

Merck

Merck focuses on a broad range of animals, investments in collaborations & partnerships, and comprehensive quality systems and processes are driving its growth in the market. It focuses on acquisitions, expansions, and collaborations, as well as product launches. In March 2017, Merck Animal Health (known as MSD Animal Health in the US and Canada) acquired Vallée S.A., a leading privately held producer of animal health products in Brazil. This helped Merck offer a comprehensive portfolio of products for livestock animals and expand its reach in Latin America.

Elanco

Elanco Animal Health is one of the largest players in the APAC animal health market. To remain competitive and grow, the company focuses on expanding and deepening its partnerships with existing customers, enhancing operations and quality, enhancing capabilities and expertise, and developing innovative products. The company pursues growth through a number of organic and inorganic growth strategies such as product launches, expansions, acquisitions, agreements, partnerships, collaborations, and divestitures, to broaden its product portfolio and grow its existing business segments. For instance, in August 2019, Elanco acquired Bayer’s Animal Health Business. This acquisition doubled Elanco’s companion animal business and advanced the company’s portfolio mix by creating a balance between its food animal and companion animal segments.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=106215485

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their pain points around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 Micro Quadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: [email protected]

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/asia-pacific-animal-health-market.asp

Visit Our Website: https://www.marketsandmarkets.com/

Content Source: https://www.marketsandmarkets.com/PressReleases/asia-pacific-animal-health.asp